Physiological function of the angiotensin AT1a receptor in bone remodeling.
about
Potential of RAS inhibition to improve metabolic bone disordersUse of renin-angiotensin system inhibitors is associated with reduction of fracture risk in hemodialysis patients.Local bone interaction between renin-angiotensin system and kallikrein-kinin system in diabetic rat.Losartan increases bone mass and accelerates chondrocyte hypertrophy in developing skeleton.Cardiovascular diseases in older patients with osteoporotic hip fracture: prevalence, disturbances in mineral and bone metabolism, and bidirectional linksSodium Intake and Osteoporosis. Findings From the Women's Health InitiativeBrain renin-angiotensin system in the nexus of hypertension and agingNon-canonical signalling and roles of the vasoactive peptides angiotensins and kinins.Role of reactive oxygen species in angiotensin II: induced receptor activator of nuclear factor-κB ligand expression in mouse osteoblastic cells.Angiotensin II suppresses osteoblastic differentiation and mineralized nodule formation via AT1 receptor in ROS17/2.8 cellsContinuous infusion of angiotensin II modulates hypertrophic differentiation and apoptosis of chondrocytes in cartilage formation in a fracture model mouse.Effects of angiotensin II type 1 receptor blocker on bones in mice with type 1 diabetes induced by streptozotocin.Gender difference in kidney electrolyte transport. I. Role of AT1a receptor in thiazide-sensitive Na+-Cl- cotransporter activity and expression in male and female mice.Angiotensin II promotes an osteoblast-like phenotype in porcine aortic valve myofibroblasts.Two-year cortical and trabecular bone loss in CKD-5D: biochemical and clinical predictors.Disruption of muscle renin-angiotensin system in AT1a-/- mice enhances muscle function despite reducing muscle mass but compromises repair after injury.Renin inhibitor aliskiren exerts beneficial effect on trabecular bone by regulating skeletal renin-angiotensin system and kallikrein-kinin system in ovariectomized mice.Early molecular responses of bone to obstructive nephropathy induced by unilateral ureteral obstruction in miceCardiovascular Interactions between Fibroblast Growth Factor-23 and Angiotensin II
P2860
Q26866515-891903EE-8253-44B0-B299-325EAA9045F9Q35391160-1578C1E4-69B1-48D9-BA60-D12F3EB82747Q35406226-15EB7B45-5F7F-484E-88F2-43F16B9D0AAAQ35588952-631D3C10-CEB2-4299-90A8-7143348D70A8Q36648170-FEECC808-89E3-4415-A50D-B079A2C22E6DQ36935590-93588D27-FB9A-467E-83C2-BA21BD2414D9Q38053075-C4CF3FEE-BA40-4808-AF93-016F565D3C59Q38190099-61718DCF-B3C5-40CB-B2CD-4360D032B197Q38971560-A2F9E904-E5B2-4AD9-B004-681A2298138EQ41253426-7660F403-81B9-4C16-9B80-1CE3262161B0Q41398780-D0676FF7-EF09-4FF3-B1F4-B660F60E8C40Q46506399-32B2C595-7CC5-4594-8D66-44E2E165C197Q47746507-5AE09095-1DBF-4505-A7B3-AD7D7BAD8EBBQ48156144-D5E0ED32-7768-463F-9B50-307D991E3258Q49375971-E5F66098-1C90-43D3-AE66-FA614FEB0C3EQ52626168-65C68782-CAB1-4B54-886E-A075B4A5AE60Q53814713-D155B0D5-0991-4A29-9679-3BD0385FE892Q57777665-5FDF01D5-B32D-4F10-B2ED-2471FB3392EFQ58770788-78A0FB33-6B22-4002-A23A-13E820F35AEE
P2860
Physiological function of the angiotensin AT1a receptor in bone remodeling.
description
2011 nî lūn-bûn
@nan
2011年の論文
@ja
2011年学术文章
@wuu
2011年学术文章
@zh
2011年学术文章
@zh-cn
2011年学术文章
@zh-hans
2011年学术文章
@zh-my
2011年学术文章
@zh-sg
2011年學術文章
@yue
2011年學術文章
@zh-hant
name
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@en
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@nl
type
label
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@en
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@nl
prefLabel
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@en
Physiological function of the angiotensin AT1a receptor in bone remodeling.
@nl
P2093
P2860
P356
P1476
Physiological function of the angiotensin AT1a receptor in bone remodeling
@en
P2093
Akiyoshi Fukamizu
Junji Ishida
Keiko Kaneko
Kyoji Ikeda
Masako Ito
Ryoji Fukuhara
P2860
P304
P356
10.1002/JBMR.501
P577
2011-12-01T00:00:00Z